BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19125855)

  • 1. The use of a single-pill calcium channel blocker/statin combination in the management of hypertension and dyslipidemia: a randomized, placebo-controlled, multicenter study.
    Neutel JM; Bestermann WH; Dyess EM; Graff A; Kursun A; Sutradhar S; Yunis C
    J Clin Hypertens (Greenwich); 2009 Jan; 11(1):22-30. PubMed ID: 19125855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial.
    Grimm R; Malik M; Yunis C; Sutradhar S; Kursun A;
    Vasc Health Risk Manag; 2010 May; 6():261-71. PubMed ID: 20479948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amlodipine + atorvastatin single pill is the most effective choice for primary prevention.
    Aalbers J
    Cardiovasc J Afr; 2010; 21(4):243. PubMed ID: 20838732
    [No Abstract]   [Full Text] [Related]  

  • 4. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
    Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).
    Erdine S; Ro YM; Tse HF; Howes LG; Aguilar-Salinas CA; Chaves H; Guindy R; Chopra P; Moller RA; Schou IM;
    J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen.
    Patel BV; Leslie RS; Thiebaud P; Nichol MB; Tang SS; Solomon H; Honda D; Foody JM
    Vasc Health Risk Manag; 2008; 4(3):673-81. PubMed ID: 18827917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial.
    Messerli FH; Bakris GL; Ferrera D; Houston MC; Petrella RJ; Flack JM; Sun W; Lee E; Neutel JM;
    J Clin Hypertens (Greenwich); 2006 Aug; 8(8):571-81; quiz 582-3. PubMed ID: 16896273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine/atorvastatin gemini study).
    Blank R; LaSalle J; Reeves R; Maroni J; Tarasenko L; Sun F
    J Clin Hypertens (Greenwich); 2005 May; 7(5):264-73. PubMed ID: 15886529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial.
    Flack JM; Victor R; Watson K; Ferdinand KC; Saunders E; Tarasenko L; Jamieson MJ; Shi H; Bruschi P
    Mayo Clin Proc; 2008 Jan; 83(1):35-45. PubMed ID: 18174006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-pill combination of amlodipine besylate and atorvastatin calcium.
    Blank R
    Drugs Today (Barc); 2006 Mar; 42(3):157-75. PubMed ID: 16628258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of fix dose combination (atorvastatin and amlodipine) in treatment of uncontrolled hypertension and dyslipidemia.
    Bashir S; Sherwani MU; Shabbir I; Batool A
    J Ayub Med Coll Abbottabad; 2011; 23(3):97-100. PubMed ID: 23272446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia.
    McKeage K; Siddiqui MA
    Am J Cardiovasc Drugs; 2008; 8(1):51-67. PubMed ID: 18303938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients.
    Fogari R; Preti P; Zoppi A; Lazzari P; Corradi L; Fogari E; Ciccarelli L; Derosa G
    Eur J Clin Pharmacol; 2006 Oct; 62(10):817-22. PubMed ID: 16896785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.
    Frishman WH; Zuckerman AL
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):675-81. PubMed ID: 15350169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
    Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
    J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFFICACY AND SAFETY OF A SINGLE-PILL COMBINATION OF ATORVASTATIN/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA.
    Naydenov Naydenov S; Margaritov Runev N; Ivanov Manov E; Georgieva Torbova-Gigova S
    Acta Clin Croat; 2018 Sep; 57(3):464-472. PubMed ID: 31168179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease.
    Curran MP
    Drugs; 2010; 70(2):191-213. PubMed ID: 20108992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.
    Richard Hobbs FD; Gensini G; John Mancini GB; Manolis AJ; Bauer B; Genest J; Feldman RD; Harvey P; Jenssen TG; da Silva PM;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):472-80. PubMed ID: 19407658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-pill combination of amlodipine besylate and atorvastatin calcium (update).
    Blank R; Hobbs FD; Zamorano J; Girerd X
    Drugs Today (Barc); 2007 Mar; 43(3):157-77. PubMed ID: 17380213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.